|
1
|
Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells.
|
Gastroenterology
|
1997
|
3.00
|
|
2
|
Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study.
|
Aliment Pharmacol Ther
|
2012
|
2.89
|
|
3
|
Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury.
|
Kidney Int
|
2007
|
2.75
|
|
4
|
Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens.
|
Gut
|
1987
|
2.44
|
|
5
|
Bioactive IL-18 expression is up-regulated in Crohn's disease.
|
J Immunol
|
1999
|
2.38
|
|
6
|
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines.
|
J Crohns Colitis
|
2013
|
1.67
|
|
7
|
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study.
|
Dig Liver Dis
|
2005
|
1.61
|
|
8
|
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
|
Dig Liver Dis
|
2005
|
1.57
|
|
9
|
Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome.
|
Am J Pathol
|
2001
|
1.57
|
|
10
|
HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation.
|
J Clin Invest
|
1998
|
1.49
|
|
11
|
[Analysis of urinary sediments in a nephrological laboratory: a precious art but too expensive?].
|
G Ital Nefrol
|
2002
|
1.39
|
|
12
|
Mucosal and systemic antibody levels against Helicobacter pylori do not parallel gastric inflammatory changes.
|
Ital J Gastroenterol Hepatol
|
1998
|
1.37
|
|
13
|
HLA-DR antigens on colonic epithelial cells in inflammatory bowel disease: I. Relation to the state of activation of lamina propria lymphocytes and to the epithelial expression of other surface markers.
|
Clin Exp Immunol
|
1987
|
1.28
|
|
14
|
A novel diagnostic tool for detecting functional patency of the small bowel: the Given patency capsule.
|
Endoscopy
|
2005
|
1.26
|
|
15
|
Immunoregulation in the gut: success and failures in human disease.
|
Gut
|
2002
|
1.25
|
|
16
|
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up.
|
Aliment Pharmacol Ther
|
2007
|
1.18
|
|
17
|
Spontaneous cytotoxicity of intestinal intraepithelial lymphocytes: clues to the mechanism.
|
Clin Exp Immunol
|
1993
|
1.16
|
|
18
|
PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis.
|
Am J Pathol
|
2000
|
1.14
|
|
19
|
Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease.
|
Am J Gastroenterol
|
1999
|
1.08
|
|
20
|
Endothelial progenitor cell-derived microvesicles improve neovascularization in a murine model of hindlimb ischemia.
|
Int J Immunopathol Pharmacol
|
2012
|
1.07
|
|
21
|
Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis.
|
Gastroenterology
|
1998
|
1.07
|
|
22
|
Alternative pathway complement activation induces proinflammatory activity in human proximal tubular epithelial cells.
|
Nephrol Dial Transplant
|
1997
|
1.06
|
|
23
|
Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide.
|
J Immunol
|
1995
|
1.05
|
|
24
|
Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells.
|
J Virol
|
1997
|
1.01
|
|
25
|
Salivary specific IgG is a sensitive indicator of the humoral immune response to Helicobacter pylori.
|
FEMS Immunol Med Microbiol
|
1995
|
0.98
|
|
26
|
Salivary-specific immunoglobulin G in the diagnosis of Helicobacter pylori infection in dyspeptic patients.
|
Am J Gastroenterol
|
1995
|
0.98
|
|
27
|
Antiangiogenic and immunomodulatory effects of rapamycin on islet endothelium: relevance for islet transplantation.
|
Am J Transplant
|
2006
|
0.97
|
|
28
|
Endoscopic vs ultrasonographic findings related to Crohn's disease recurrence: a prospective longitudinal study at 3 years.
|
J Crohns Colitis
|
2010
|
0.96
|
|
29
|
Heparin-binding domain of human fibronectin binds HIV-1 gp120/160 and reduces virus infectivity.
|
J Med Virol
|
1998
|
0.95
|
|
30
|
Outer-membrane porins from gram-negative bacteria stimulate platelet-activating-factor biosynthesis by cultured human endothelial cells.
|
Eur J Biochem
|
1993
|
0.94
|
|
31
|
Salmonella typhimurium porins stimulate platelet-activating factor synthesis by human polymorphonuclear neutrophils.
|
J Immunol
|
1992
|
0.93
|
|
32
|
Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model.
|
Arterioscler Thromb Vasc Biol
|
2000
|
0.90
|
|
33
|
Immunotoxins containing recombinant anti-CTLA-4 single-chain fragment variable antibodies and saporin: in vitro results and in vivo effects in an acute rejection model.
|
J Immunol
|
2001
|
0.89
|
|
34
|
Isotypic analysis of specific antibody response in serum, saliva, gastric and rectal homogenates of Helicobacter pylori-infected patients.
|
FEMS Immunol Med Microbiol
|
1995
|
0.89
|
|
35
|
Helicobacter pylori-specific IgG in chronic haemodialysis patients: relationship of hypergastrinaemia to positive serology.
|
Nephrol Dial Transplant
|
1996
|
0.88
|
|
36
|
Unsedated transnasal versus transoral sedated upper gastrointestinal endoscopy: a one-series prospective study on safety and patient acceptability.
|
Dig Liver Dis
|
2008
|
0.87
|
|
37
|
HIV-persistent infection and cytokine induction in mesangial cells: a potential mechanism for HIV-associated glomerulosclerosis.
|
AIDS
|
2000
|
0.87
|
|
38
|
HIV type 1 Tat protein is a survival factor for Kaposi's sarcoma and endothelial cells.
|
AIDS Res Hum Retroviruses
|
2001
|
0.87
|
|
39
|
Transglutaminases in Crohn's disease.
|
Gut
|
1995
|
0.87
|
|
40
|
Interleukin-25 production is differently regulated by TNF-α and TGF-β1 in the human gut.
|
Mucosal Immunol
|
2010
|
0.86
|
|
41
|
Effect of platelet-activating factor receptor expression on CHO cell motility.
|
J Cell Physiol
|
2000
|
0.86
|
|
42
|
3020insC mutation within the NOD2 gene in Crohn's disease: frequency and association with clinical pattern in an Italian population.
|
Dig Liver Dis
|
2002
|
0.86
|
|
43
|
Interleukin-23R Arg381Gln is associated with susceptibility to Crohn's disease but not with phenotype in an Italian population.
|
Gastroenterology
|
2007
|
0.84
|
|
44
|
A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn’s disease.
|
Aliment Pharmacol Ther
|
2012
|
0.84
|
|
45
|
Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change.
|
Am J Pathol
|
1999
|
0.84
|
|
46
|
I-interleukin-2 scintigraphy: a new approach to assess disease activity in autoimmunity.
|
J Pediatr Endocrinol Metab
|
1996
|
0.83
|
|
47
|
Platelet-activating factor-induced endothelial cell expression of adhesion molecules and modulation of surface glycocalyx, evaluated by electron spectroscopy chemical analysis.
|
Semin Thromb Hemost
|
1994
|
0.83
|
|
48
|
Tat-induced platelet-activating factor synthesis contributes to the angiogenic effect of HIV-1 Tat.
|
Eur J Immunol
|
2001
|
0.83
|
|
49
|
123I-interleukin-2 scintigraphy for in vivo assessment of intestinal mononuclear cell infiltration in Crohn's disease.
|
J Nucl Med
|
2000
|
0.83
|
|
50
|
Effect of cytokines on the cytoskeleton of resident glomerular cells.
|
Kidney Int Suppl
|
1993
|
0.83
|
|
51
|
T cell differentiation antigens expressed by peripheral blood lymphocytes in Crohn's disease.
|
Boll Ist Sieroter Milan
|
1985
|
0.83
|
|
52
|
The synthesis of platelet-activating factor modulates chemotaxis of monocytes induced by HIV-1 Tat.
|
Eur J Immunol
|
1999
|
0.82
|
|
53
|
Porins and lipopolysaccharide stimulate platelet activating factor synthesis by human mesangial cells.
|
Kidney Int
|
1992
|
0.81
|
|
54
|
Evidence against colonic mucosa colonisation by Helicobacter pylori. Lack of a specific antibody response in homogenates of rectal endoscopic biopsies.
|
Ital J Gastroenterol
|
1997
|
0.80
|
|
55
|
The expression of CD154 by Kaposi's sarcoma cells mediates the anti-apoptotic and migratory effects of HIV-1-TAT protein.
|
Int J Immunopathol Pharmacol
|
2006
|
0.80
|
|
56
|
Effect of immunosuppressive therapy on patients with inflammatory bowel diseases and hepatitis B or C virus infection.
|
J Viral Hepat
|
2012
|
0.80
|
|
57
|
Development of a high-performance liquid chromatographic-mass spectrometric technique, with an ionspray interface, for the determination of platelet-activating factor (PAF) and lyso-PAF in biological samples.
|
J Chromatogr
|
1993
|
0.80
|
|
58
|
Adenoma, advanced adenoma and colorectal cancer prevalence in asymptomatic 40- to 49-year-old subjects with a first-degree family history of colorectal cancer.
|
Colorectal Dis
|
2013
|
0.80
|
|
59
|
Antineutrophil cytoplasmic antibodies are present in long standing type 1 diabetics but do not correlate with selective proteinuria.
|
J Autoimmun
|
1996
|
0.79
|
|
60
|
Altered IgG(4) renal clearance in patients with inflammatory bowel diseases. Evidence for a subclinical impairment of protein charge renal selectivity.
|
Nephrol Dial Transplant
|
2000
|
0.78
|
|
61
|
Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation.
|
Gut
|
2008
|
0.78
|
|
62
|
Assessment of cardiovascular risk in waiting-listed renal transplant patients: a single center experience in 558 cases.
|
Clin Transplant
|
2009
|
0.77
|
|
63
|
The role of E-selectin for neutrophil activation and tumor metastasis in vivo.
|
Leukemia
|
1997
|
0.77
|
|
64
|
Role of the membrane attack complex of complement in lung injury mediated by antibodies to endothelium.
|
Int Arch Allergy Immunol
|
1993
|
0.77
|
|
65
|
Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNFalpha reduce colitis-associated colorectal carcinogenesis?
|
Gut
|
2009
|
0.77
|
|
66
|
IL-4 hyporesponsiveness of Crohn's disease mucosal T lymphocytes: a response of polarised Th1 cells?
|
Dig Liver Dis
|
2001
|
0.75
|
|
67
|
In vivo modulation of CD26 (dipeptidyl peptidase IV) in the mouse: effects of polyreactive and monoreactive antibodies.
|
Transplantation
|
1996
|
0.75
|
|
68
|
[Crohn disease: etiopathogenesis].
|
Ann Ital Chir
|
1995
|
0.75
|
|
69
|
Production of tumor necrosis factor-alpha in patients on hemodiafiltration.
|
Nephron
|
1992
|
0.75
|
|
70
|
Detection of platelet-activating factor in plasma of patients with streptococcal nephritis.
|
J Am Soc Nephrol
|
1993
|
0.75
|
|
71
|
[Daily dialysis: evaluation of the first year of experience at home and in a limited care center].
|
Minerva Urol Nefrol
|
2002
|
0.75
|
|
72
|
Role of platelet activating factor in hemodialysis.
|
Kidney Int Suppl
|
1993
|
0.75
|
|
73
|
Henoch-Schönlein purpura after 20 years of renal replacement therapy.
|
J Nephrol
|
2001
|
0.75
|
|
74
|
A case report of AA amyloidosis associated with familial periodic fever syndrome diagnosed after kidney transplantation: never say never.
|
Transplant Proc
|
2013
|
0.75
|
|
75
|
Perceptual defense mechanisms in Crohn's disease and panic disorder.
|
Percept Mot Skills
|
1999
|
0.75
|
|
76
|
Evidence against an increased risk of Helicobacter pylori infection in dentists: a serological and salivary study.
|
Eur J Gastroenterol Hepatol
|
1995
|
0.75
|
|
77
|
Hypertensive rebound after angiotensin converting enzyme inhibitor withdrawal in diabetic patients with chronic renal failure.
|
Nephrol Dial Transplant
|
2001
|
0.75
|
|
78
|
Teaching technology with technology: computer assisted lessons in the medical school the first Italian experience in nephrology and dialysis.
|
Int J Artif Organs
|
2002
|
0.75
|
|
79
|
Lansoprazole and Helicobacter pylori infection.
|
Clin Ther
|
1993
|
0.75
|